Patents

US 11179369 B2: Sustained release pharmaceutical compositions

Granted
2021-11-23
Filed
2019-11-01 application 16672296
Type
Utility · 17 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.

Source: PVGPATDIS, file of 2026-04-10 (ipg211123.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Wyeth, LLC 476 patentsUS company or organizationMadison, NJPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Eric BenjaminJamestown, NC11PVGPATDIS, file of 2026-04-10
Wendy Ann DulinRamapo, NY4PVGPATDIS, file of 2026-04-10
Yanning LinLake Hiawatha, NJ3PVGPATDIS, file of 2026-04-10
Kai ZhuangRiver Edge, NJ3PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/407PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.